InvestorsHub Logo
Followers 8
Posts 470
Boards Moderated 0
Alias Born 12/03/2012

Re: BonelessCat post# 25148

Saturday, 02/23/2013 5:47:05 PM

Saturday, February 23, 2013 5:47:05 PM

Post# of 403316
Dr. F, Thanks for this VERY concise and hopeful indicator. I appreciate your DD, truly.



DrFeelgood Member Profile DrFeelgood Member Level

Saturday, February 23, 2013 5:31:11 PM
Re: Brenum post# 25146
Post # of 25148
Much of that process does not apply to Kevetrin or Prurisol, if both work as expected. With excellent Phase 1 results, Kevetrin will qualify for unmet need against stage 4 highly resistant solid tumor cancers. At the least, it will jump from Phase 1 to Phase 3 since much of Phase 2 is already designed into the current trial. Best case, if Phase 1 results align with animal efficacy and tox studies, it will be designated a breakthrough therapy and immediately approved for clinical use and marketing against high resistance tumors, without further testing.

Prurisol is already entering Phase 2/3a testing in Europe, and with decent results there, should be approved for pivotal Phase 3 testing in the US. So, both drugs are farther advanced in the human testing process than the FDA "Drug Review Process" would indicate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News